Structure

Physi-Chem Properties

Molecular Weight:  434.17
Volume:  456.323
LogP:  5.08
LogD:  3.531
LogS:  -4.011
# Rotatable Bonds:  6
TPSA:  93.06
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.476
Synthetic Accessibility Score:  3.261
Fsp3:  0.231
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.974
MDCK Permeability:  1.2175421943538822e-05
Pgp-inhibitor:  0.965
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.038
20% Bioavailability (F20%):  0.054
30% Bioavailability (F30%):  0.083

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.035
Plasma Protein Binding (PPB):  100.4542007446289%
Volume Distribution (VD):  0.283
Pgp-substrate:  1.1337244510650635%

ADMET: Metabolism

CYP1A2-inhibitor:  0.309
CYP1A2-substrate:  0.756
CYP2C19-inhibitor:  0.134
CYP2C19-substrate:  0.122
CYP2C9-inhibitor:  0.9
CYP2C9-substrate:  0.301
CYP2D6-inhibitor:  0.837
CYP2D6-substrate:  0.132
CYP3A4-inhibitor:  0.362
CYP3A4-substrate:  0.263

ADMET: Excretion

Clearance (CL):  0.754
Half-life (T1/2):  0.159

ADMET: Toxicity

hERG Blockers:  0.112
Human Hepatotoxicity (H-HT):  0.931
Drug-inuced Liver Injury (DILI):  0.977
AMES Toxicity:  0.018
Rat Oral Acute Toxicity:  0.943
Maximum Recommended Daily Dose:  0.91
Skin Sensitization:  0.287
Carcinogencity:  0.731
Eye Corrosion:  0.003
Eye Irritation:  0.014
Respiratory Toxicity:  0.675

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469953

Natural Product ID:  NPC469953
Common Name*:   3-[7-Hydroxy-5-Methoxy-2,2-Dimethyl-6-(2-Methyl-But-2-Enoyl)-2H-Chromen-8-Yl]-3-Phenyl-Acrylic Acid
IUPAC Name:   (E)-3-[7-hydroxy-5-methoxy-2,2-dimethyl-6-[(E)-2-methylbut-2-enoyl]chromen-8-yl]-3-phenylprop-2-enoic acid
Synonyms:  
Standard InCHIKey:  ITDQXOISWWDOGP-MSBMPMNRSA-N
Standard InCHI:  InChI=1S/C26H26O6/c1-6-15(2)22(29)21-23(30)20(18(14-19(27)28)16-10-8-7-9-11-16)25-17(24(21)31-5)12-13-26(3,4)32-25/h6-14,30H,1-5H3,(H,27,28)/b15-6+,18-14+
SMILES:  C/C=C(/C(=O)c1c(O)c(/C(=C/C(=O)O)/c2ccccc2)c2c(c1OC)C=CC(O2)(C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL133575
PubChem CID:   44354054
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0003522] 2,2-dimethyl-1-benzopyrans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. n.a. n.a. PMID[15678383]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. n.a. n.a. PMID[16045947]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. stem n.a. PMID[20188156]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. Malaysian n.a. PMID[7506311]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT459 Individual Protein Human immunodeficiency virus type 1 reverse transcriptase Human immunodeficiency virus 1 IC50 > 100000.0 nM PMID[479016]
NPT112 Cell Line MOLT-4 Homo sapiens IC50 = 4500.0 nM PMID[479016]
NPT165 Cell Line HeLa Homo sapiens IC50 = 36400.0 nM PMID[479017]
NPT886 Cell Line NIH3T3 Mus musculus CC50 = 41100.0 nM PMID[479017]
NPT116 Cell Line HL-60 Homo sapiens IC50 = 2200.0 nM PMID[479017]
NPT2 Others Unspecified Ratio CC50/IC50 = 19.2 n.a. PMID[479017]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469953 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9716 High Similarity NPC180477
0.9712 High Similarity NPC36181
0.9712 High Similarity NPC226636
0.9712 High Similarity NPC11561
0.9645 High Similarity NPC57470
0.9645 High Similarity NPC470322
0.9643 High Similarity NPC94794
0.9643 High Similarity NPC188632
0.9643 High Similarity NPC112791
0.9643 High Similarity NPC196459
0.9643 High Similarity NPC87609
0.9643 High Similarity NPC470296
0.964 High Similarity NPC205006
0.964 High Similarity NPC147688
0.964 High Similarity NPC110969
0.964 High Similarity NPC103362
0.964 High Similarity NPC156590
0.964 High Similarity NPC64908
0.964 High Similarity NPC118840
0.9638 High Similarity NPC217186
0.9638 High Similarity NPC53181
0.958 High Similarity NPC104236
0.958 High Similarity NPC164205
0.9577 High Similarity NPC249942
0.9577 High Similarity NPC297886
0.9577 High Similarity NPC140120
0.9574 High Similarity NPC178627
0.9574 High Similarity NPC311741
0.9574 High Similarity NPC196137
0.9574 High Similarity NPC469935
0.9574 High Similarity NPC1886
0.9574 High Similarity NPC234629
0.9568 High Similarity NPC475680
0.9568 High Similarity NPC235239
0.9568 High Similarity NPC261227
0.9568 High Similarity NPC241100
0.9568 High Similarity NPC159275
0.9568 High Similarity NPC172986
0.9568 High Similarity NPC270883
0.9568 High Similarity NPC305355
0.9568 High Similarity NPC150522
0.9514 High Similarity NPC151973
0.951 High Similarity NPC469933
0.951 High Similarity NPC161864
0.951 High Similarity NPC208303
0.9507 High Similarity NPC181388
0.9507 High Similarity NPC154217
0.9504 High Similarity NPC18585
0.9504 High Similarity NPC166138
0.9504 High Similarity NPC106985
0.9504 High Similarity NPC38219
0.95 High Similarity NPC282300
0.9496 High Similarity NPC301217
0.9496 High Similarity NPC220062
0.9496 High Similarity NPC78913
0.9496 High Similarity NPC96565
0.9496 High Similarity NPC216978
0.9496 High Similarity NPC303633
0.9496 High Similarity NPC55018
0.9496 High Similarity NPC18260
0.9444 High Similarity NPC469932
0.9444 High Similarity NPC19238
0.9441 High Similarity NPC23728
0.9441 High Similarity NPC104406
0.9441 High Similarity NPC24673
0.9441 High Similarity NPC79469
0.9441 High Similarity NPC201731
0.9441 High Similarity NPC110303
0.9441 High Similarity NPC97716
0.9441 High Similarity NPC237635
0.9437 High Similarity NPC209040
0.9437 High Similarity NPC278175
0.9437 High Similarity NPC257236
0.9433 High Similarity NPC59739
0.9433 High Similarity NPC78803
0.9433 High Similarity NPC266725
0.9433 High Similarity NPC214236
0.9433 High Similarity NPC293852
0.9433 High Similarity NPC62840
0.9433 High Similarity NPC144499
0.9433 High Similarity NPC217083
0.9433 High Similarity NPC299080
0.9429 High Similarity NPC221173
0.9429 High Similarity NPC69769
0.9424 High Similarity NPC272844
0.9424 High Similarity NPC201395
0.9424 High Similarity NPC248995
0.9424 High Similarity NPC254168
0.9379 High Similarity NPC474735
0.9375 High Similarity NPC266572
0.9375 High Similarity NPC132592
0.9375 High Similarity NPC160821
0.9375 High Similarity NPC6511
0.9371 High Similarity NPC312973
0.9371 High Similarity NPC88964
0.9371 High Similarity NPC470647
0.9371 High Similarity NPC83357
0.9371 High Similarity NPC142405
0.9371 High Similarity NPC54577
0.9371 High Similarity NPC477955
0.9371 High Similarity NPC475052
0.9371 High Similarity NPC20488
0.9371 High Similarity NPC246948
0.9371 High Similarity NPC67805
0.9371 High Similarity NPC301276
0.9371 High Similarity NPC111786
0.9371 High Similarity NPC195621
0.9371 High Similarity NPC124729
0.9371 High Similarity NPC267375
0.9371 High Similarity NPC176229
0.9371 High Similarity NPC214774
0.9366 High Similarity NPC214166
0.9366 High Similarity NPC91560
0.9366 High Similarity NPC75049
0.9366 High Similarity NPC221432
0.9366 High Similarity NPC164980
0.9366 High Similarity NPC68104
0.9366 High Similarity NPC219915
0.9366 High Similarity NPC169591
0.9366 High Similarity NPC316816
0.9366 High Similarity NPC175504
0.9366 High Similarity NPC39329
0.9366 High Similarity NPC149026
0.9366 High Similarity NPC478086
0.9366 High Similarity NPC310130
0.9366 High Similarity NPC257097
0.9366 High Similarity NPC143896
0.9366 High Similarity NPC150408
0.9362 High Similarity NPC110038
0.9362 High Similarity NPC3188
0.9362 High Similarity NPC248372
0.9362 High Similarity NPC470555
0.9357 High Similarity NPC472343
0.9357 High Similarity NPC240305
0.9357 High Similarity NPC283429
0.9357 High Similarity NPC23257
0.9353 High Similarity NPC317119
0.9353 High Similarity NPC266597
0.9353 High Similarity NPC250266
0.9348 High Similarity NPC101752
0.9348 High Similarity NPC156092
0.9315 High Similarity NPC290671
0.9306 High Similarity NPC283234
0.9306 High Similarity NPC296998
0.9306 High Similarity NPC473077
0.9301 High Similarity NPC131568
0.9301 High Similarity NPC236766
0.9301 High Similarity NPC319752
0.9301 High Similarity NPC473015
0.9301 High Similarity NPC197252
0.9301 High Similarity NPC273538
0.9301 High Similarity NPC131579
0.9301 High Similarity NPC473013
0.9301 High Similarity NPC216538
0.9296 High Similarity NPC10937
0.9296 High Similarity NPC64915
0.9296 High Similarity NPC324134
0.9296 High Similarity NPC227579
0.9296 High Similarity NPC37496
0.9296 High Similarity NPC324436
0.9296 High Similarity NPC223500
0.9296 High Similarity NPC328164
0.9296 High Similarity NPC40833
0.9296 High Similarity NPC265040
0.9296 High Similarity NPC76338
0.9296 High Similarity NPC1089
0.9296 High Similarity NPC296917
0.9296 High Similarity NPC161506
0.9296 High Similarity NPC32739
0.9296 High Similarity NPC200694
0.9296 High Similarity NPC78
0.9296 High Similarity NPC66515
0.9296 High Similarity NPC306829
0.9296 High Similarity NPC194432
0.9296 High Similarity NPC166482
0.9296 High Similarity NPC177354
0.9296 High Similarity NPC220998
0.9296 High Similarity NPC125855
0.9296 High Similarity NPC182852
0.9296 High Similarity NPC107572
0.9296 High Similarity NPC76372
0.9296 High Similarity NPC228504
0.9296 High Similarity NPC147145
0.9296 High Similarity NPC148757
0.9296 High Similarity NPC166934
0.9296 High Similarity NPC167624
0.9291 High Similarity NPC219917
0.9291 High Similarity NPC471587
0.9291 High Similarity NPC215311
0.9291 High Similarity NPC213659
0.9291 High Similarity NPC144118
0.9291 High Similarity NPC80962
0.9291 High Similarity NPC172250
0.9291 High Similarity NPC259166
0.9291 High Similarity NPC204985
0.9291 High Similarity NPC48624
0.9291 High Similarity NPC326109
0.9286 High Similarity NPC470669
0.9286 High Similarity NPC21350
0.9286 High Similarity NPC124269

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469953 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9437 High Similarity NPD7410 Clinical (unspecified phase)
0.9301 High Similarity NPD4378 Clinical (unspecified phase)
0.9184 High Similarity NPD7411 Suspended
0.9014 High Similarity NPD1549 Phase 2
0.9007 High Similarity NPD7075 Discontinued
0.8993 High Similarity NPD6801 Discontinued
0.8944 High Similarity NPD1552 Clinical (unspecified phase)
0.8944 High Similarity NPD1550 Clinical (unspecified phase)
0.8936 High Similarity NPD1510 Phase 2
0.8933 High Similarity NPD7096 Clinical (unspecified phase)
0.8933 High Similarity NPD7819 Suspended
0.8921 High Similarity NPD1240 Approved
0.8873 High Similarity NPD2796 Approved
0.8836 High Similarity NPD6799 Approved
0.8819 High Similarity NPD7421 Clinical (unspecified phase)
0.8794 High Similarity NPD1607 Approved
0.8759 High Similarity NPD3750 Approved
0.8733 High Similarity NPD4380 Phase 2
0.8693 High Similarity NPD7768 Phase 2
0.8684 High Similarity NPD2393 Clinical (unspecified phase)
0.8662 High Similarity NPD7852 Clinical (unspecified phase)
0.8627 High Similarity NPD8443 Clinical (unspecified phase)
0.8609 High Similarity NPD6599 Discontinued
0.8562 High Similarity NPD1243 Approved
0.8516 High Similarity NPD3749 Approved
0.8516 High Similarity NPD4381 Clinical (unspecified phase)
0.8511 High Similarity NPD2313 Discontinued
0.8511 High Similarity NPD6859 Clinical (unspecified phase)
0.8493 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8483 Intermediate Similarity NPD2935 Discontinued
0.8483 Intermediate Similarity NPD1551 Phase 2
0.8456 Intermediate Similarity NPD1511 Approved
0.8442 Intermediate Similarity NPD2801 Approved
0.8414 Intermediate Similarity NPD2799 Discontinued
0.8414 Intermediate Similarity NPD3748 Approved
0.8411 Intermediate Similarity NPD5403 Approved
0.8411 Intermediate Similarity NPD920 Approved
0.8389 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8387 Intermediate Similarity NPD3817 Phase 2
0.8377 Intermediate Similarity NPD1934 Approved
0.8344 Intermediate Similarity NPD1512 Approved
0.8311 Intermediate Similarity NPD2800 Approved
0.8286 Intermediate Similarity NPD1203 Approved
0.8282 Intermediate Similarity NPD5953 Discontinued
0.8278 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8278 Intermediate Similarity NPD2532 Approved
0.8278 Intermediate Similarity NPD5401 Approved
0.8278 Intermediate Similarity NPD2534 Approved
0.8278 Intermediate Similarity NPD2533 Approved
0.8276 Intermediate Similarity NPD6651 Approved
0.8272 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8272 Intermediate Similarity NPD7286 Phase 2
0.8255 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD3882 Suspended
0.8187 Intermediate Similarity NPD6232 Discontinued
0.8163 Intermediate Similarity NPD7033 Discontinued
0.8148 Intermediate Similarity NPD7473 Discontinued
0.8125 Intermediate Similarity NPD3268 Approved
0.8125 Intermediate Similarity NPD6959 Discontinued
0.8112 Intermediate Similarity NPD6832 Phase 2
0.8101 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8098 Intermediate Similarity NPD3818 Discontinued
0.8082 Intermediate Similarity NPD5124 Phase 1
0.8082 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.8071 Intermediate Similarity NPD9717 Approved
0.8065 Intermediate Similarity NPD3226 Approved
0.8054 Intermediate Similarity NPD2346 Discontinued
0.8041 Intermediate Similarity NPD4308 Phase 3
0.8038 Intermediate Similarity NPD5402 Approved
0.8028 Intermediate Similarity NPD2797 Approved
0.8013 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.8013 Intermediate Similarity NPD4628 Phase 3
0.8012 Intermediate Similarity NPD6559 Discontinued
0.8 Intermediate Similarity NPD422 Phase 1
0.8 Intermediate Similarity NPD919 Approved
0.7975 Intermediate Similarity NPD6166 Phase 2
0.7975 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD5494 Approved
0.7939 Intermediate Similarity NPD5844 Phase 1
0.7939 Intermediate Similarity NPD7054 Approved
0.7933 Intermediate Similarity NPD2344 Approved
0.7892 Intermediate Similarity NPD7472 Approved
0.7892 Intermediate Similarity NPD7074 Phase 3
0.7857 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7847 Intermediate Similarity NPD2798 Approved
0.7844 Intermediate Similarity NPD6797 Phase 2
0.7832 Intermediate Similarity NPD3225 Approved
0.7829 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.78 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD7251 Discontinued
0.7785 Intermediate Similarity NPD6585 Discontinued
0.7778 Intermediate Similarity NPD3267 Approved
0.7778 Intermediate Similarity NPD3266 Approved
0.777 Intermediate Similarity NPD4307 Phase 2
0.7755 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7751 Intermediate Similarity NPD7808 Phase 3
0.7748 Intermediate Similarity NPD6100 Approved
0.7748 Intermediate Similarity NPD6099 Approved
0.7746 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD5889 Approved
0.7736 Intermediate Similarity NPD5890 Approved
0.7727 Intermediate Similarity NPD2309 Approved
0.7718 Intermediate Similarity NPD1933 Approved
0.7714 Intermediate Similarity NPD1548 Phase 1
0.7714 Intermediate Similarity NPD9545 Approved
0.7707 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD4288 Approved
0.7698 Intermediate Similarity NPD9493 Approved
0.7651 Intermediate Similarity NPD943 Approved
0.7643 Intermediate Similarity NPD5049 Phase 3
0.764 Intermediate Similarity NPD1465 Phase 2
0.7636 Intermediate Similarity NPD5711 Approved
0.7636 Intermediate Similarity NPD5710 Approved
0.7635 Intermediate Similarity NPD1296 Phase 2
0.7635 Intermediate Similarity NPD3764 Approved
0.7633 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD5405 Approved
0.7632 Intermediate Similarity NPD5406 Approved
0.7632 Intermediate Similarity NPD5408 Approved
0.7632 Intermediate Similarity NPD5404 Approved
0.7619 Intermediate Similarity NPD4908 Phase 1
0.761 Intermediate Similarity NPD7458 Discontinued
0.76 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD4287 Approved
0.7582 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD1247 Approved
0.7569 Intermediate Similarity NPD1608 Approved
0.7548 Intermediate Similarity NPD7003 Approved
0.7534 Intermediate Similarity NPD1164 Approved
0.7517 Intermediate Similarity NPD6798 Discontinued
0.7517 Intermediate Similarity NPD411 Approved
0.7516 Intermediate Similarity NPD7390 Discontinued
0.7514 Intermediate Similarity NPD4363 Phase 3
0.7514 Intermediate Similarity NPD4360 Phase 2
0.75 Intermediate Similarity NPD2354 Approved
0.75 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1610 Phase 2
0.75 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD3926 Phase 2
0.7484 Intermediate Similarity NPD2654 Approved
0.7483 Intermediate Similarity NPD230 Phase 1
0.7483 Intermediate Similarity NPD447 Suspended
0.7483 Intermediate Similarity NPD1019 Discontinued
0.7472 Intermediate Similarity NPD4361 Phase 2
0.7472 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD1729 Discontinued
0.7468 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD4625 Phase 3
0.7448 Intermediate Similarity NPD3972 Approved
0.744 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD7229 Phase 3
0.7405 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD3887 Approved
0.7361 Intermediate Similarity NPD17 Approved
0.7355 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD2353 Approved
0.7353 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD7584 Approved
0.7343 Intermediate Similarity NPD1894 Discontinued
0.7329 Intermediate Similarity NPD1481 Phase 2
0.7299 Intermediate Similarity NPD8312 Approved
0.7299 Intermediate Similarity NPD8313 Approved
0.729 Intermediate Similarity NPD4476 Approved
0.729 Intermediate Similarity NPD4477 Approved
0.7289 Intermediate Similarity NPD6971 Discontinued
0.7273 Intermediate Similarity NPD8434 Phase 2
0.7267 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD7199 Phase 2
0.7261 Intermediate Similarity NPD1652 Phase 2
0.726 Intermediate Similarity NPD1535 Discovery
0.7255 Intermediate Similarity NPD6355 Discontinued
0.7251 Intermediate Similarity NPD7177 Discontinued
0.7244 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD6005 Phase 3
0.7244 Intermediate Similarity NPD6004 Phase 3
0.7244 Intermediate Similarity NPD6002 Phase 3
0.7244 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7237 Intermediate Similarity NPD6233 Phase 2
0.7234 Intermediate Similarity NPD1241 Discontinued
0.7233 Intermediate Similarity NPD7440 Discontinued
0.7213 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD6273 Approved
0.7191 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD4060 Phase 1
0.7184 Intermediate Similarity NPD6104 Discontinued
0.7181 Intermediate Similarity NPD1470 Approved
0.7176 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD2296 Approved
0.7163 Intermediate Similarity NPD5535 Approved
0.7162 Intermediate Similarity NPD4749 Approved
0.7152 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD5940 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD3751 Discontinued
0.7143 Intermediate Similarity NPD1201 Approved
0.7134 Intermediate Similarity NPD1471 Phase 3
0.7134 Intermediate Similarity NPD6502 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data